RecruitingNot ApplicableNCT06840587

Connect-Home: Alzheimer's Disease and Related Dementias

Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial

Sponsor

University of North Carolina, Chapel Hill

Enrollment

360 participants

Start Date

Apr 4, 2025

Study Type

INTERVENTIONAL

Conditions

Dementia Alzheimer Disease

Summary

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Eligibility

Min Age: 19 Years

Inclusion Criteria10

Patients:
Ability to speak English
Goal of discharge to home, assisted living, or long-term care
Diagnosis of dementia
Having a caregiver willing to participate
Caregivers:
Ability to speak English
Legally authorized representative (LAR) who also provides support for the person with ADRD
Location within 120 miles of UNC-Chapel Hill
Admission of at least 75 SNF patients per year

Exclusion Criteria4

Patients:
Planned hospital readmission for procedures or treatments within 30 days post enrollment.
Caregivers:
LAR is a court-appointed guardian.

Interventions

BEHAVIORALConnect-Home ADRD

Connect-Home ADRD will introduce new structure and processes to support SNF staff delivery of transitional care for transitions to home, assisted living, or long-term care, and post-discharge transitional care by the Dementia Caregiving Specialist.